CALIMAN, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 1.635
AS - Asia 1.511
EU - Europa 1.380
SA - Sud America 106
AF - Africa 31
OC - Oceania 22
Totale 4.685
Nazione #
US - Stati Uniti d'America 1.597
RU - Federazione Russa 530
SG - Singapore 474
CN - Cina 465
IT - Italia 393
HK - Hong Kong 180
KR - Corea 126
VN - Vietnam 102
IE - Irlanda 96
BR - Brasile 89
FR - Francia 61
PL - Polonia 60
DE - Germania 59
FI - Finlandia 54
IN - India 49
SE - Svezia 38
GB - Regno Unito 29
JO - Giordania 27
ID - Indonesia 22
AU - Australia 21
CA - Canada 19
BD - Bangladesh 17
NL - Olanda 16
JP - Giappone 11
NG - Nigeria 11
CH - Svizzera 10
AT - Austria 8
IQ - Iraq 8
MX - Messico 8
ES - Italia 7
PK - Pakistan 6
PH - Filippine 5
UA - Ucraina 5
UZ - Uzbekistan 5
AR - Argentina 4
CL - Cile 4
EC - Ecuador 4
MA - Marocco 4
BJ - Benin 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
KE - Kenya 2
LT - Lituania 2
TR - Turchia 2
ZA - Sudafrica 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.685
Città #
Santa Clara 456
Singapore 363
Ashburn 323
Hefei 169
Hong Kong 161
Seoul 126
San Jose 112
Dublin 96
Florence 68
Warsaw 58
Beijing 50
Los Angeles 46
Milan 46
Council Bluffs 45
Chandler 40
The Dalles 37
Helsinki 34
Munich 34
Buffalo 32
Rome 32
Dallas 31
Ho Chi Minh City 29
Paris 29
Hanoi 25
New York 25
Jakarta 22
Lauterbourg 22
Melbourne 21
Kent 20
Boardman 19
Shanghai 18
Moscow 17
Fairfield 16
Mumbai 16
Bengaluru 12
London 12
Seattle 12
Abuja 11
Tokyo 11
Turku 11
Altamura 9
Boston 9
Woodbridge 9
Frankfurt am Main 8
Houston 8
Lappeenranta 8
Lawrence 8
Naples 8
Vienna 8
Orem 7
Pune 7
São Paulo 7
Brescia 6
Chennai 6
Haiphong 6
Toronto 5
Acton 4
Ancona 4
Bern 4
Brooklyn 4
Douglasville 4
Elk Grove Village 4
Genoa 4
Guangzhou 4
Lahore 4
Montreal 4
Nuremberg 4
Ottawa 4
Ovada 4
Palermo 4
Princeton 4
Rio de Janeiro 4
Verona 4
Wilmington 4
Yubileyny 4
Zhengzhou 4
Alba 3
Amsterdam 3
Bremen 3
Buenos Aires 3
Chicago 3
Cotonou 3
Dhaka 3
Duque de Caxias 3
Lecce 3
Macerata 3
Madrid 3
Olomouc 3
Oslo 3
Phoenix 3
Piscataway 3
Poplar 3
Recanati 3
Ribeirão Preto 3
San Diego 3
San Francisco 3
San Marco Evangelista 3
Scandicci 3
Stockholm 3
Tashkent 3
Totale 2.978
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 281
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 255
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 246
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 236
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 232
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 211
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 197
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 188
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 183
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 180
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 178
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 178
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 176
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 170
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 170
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 167
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 162
Induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (Hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report 159
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 158
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 157
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 133
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 130
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 128
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 124
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 121
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm? 78
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 69
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC 49
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma 30
Totale 4.746
Categoria #
all - tutte 14.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202227 0 2 1 0 0 2 2 5 0 2 3 10
2022/2023302 7 27 5 29 15 52 45 37 47 13 16 9
2023/2024358 10 14 27 19 24 47 23 77 11 19 35 52
2024/20251.758 63 161 93 274 392 223 53 104 95 58 102 140
2025/20262.183 296 301 307 176 226 73 287 108 146 165 78 20
Totale 4.746